Impact of the COVID-19 pandemic on testing services for HIV, viral hepatitis and sexually transmitted infections in the WHO European Region, March to August 2020
Daniel Simões, Annemarie Rinder Stengaard, Lauren Combs, Dorthe Raben
Abstract
We present preliminary results of a coronavirus disease (COVID-19) impact assessment on testing for HIV, viral hepatitis and sexually transmitted infections in the WHO European Region. We analyse 98 responses from secondary care (n = 36), community testing sites (n = 52) and national level (n = 10). Compared to pre-COVID-19, 95% of respondents report decreased testing volumes during March-May and 58% during June-August 2020. Reasons for decreases and mitigation measures were analysed.
Topics & Concepts
PandemicCoronavirus disease 2019 (COVID-19)MedicineViral hepatitisVirologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakHuman immunodeficiency virus (HIV)Hepatitis CCoronavirusEnvironmental healthDiseaseInfectious disease (medical specialty)Internal medicineOutbreakHIV/AIDS Research and InterventionsHIV, Drug Use, Sexual RiskFood Security and Health in Diverse Populations